skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Overview of essential tremor

Review

(2925) Views  (1204) Full article downloads

Authors: Theresa A Zesiewicz, Abinaya Chari, Israt Jahan, et al

Published Date July 2010 Volume 2010:6(1) Pages 401 - 408
DOI: http://dx.doi.org/10.2147/NDT.S4795

Theresa A Zesiewicz, Abinaya Chari, Israt Jahan, Amber M Miller, Kelly L Sullivan

Department of Neurology, Parkinson Research Foundation, James A. Haley Veterans Administration Hospital,
University of South Florida, Tampa, FL, USA

Abstract: Essential tremor (ET) is one of the most common movement disorders in the world. Despite this, only one medication (propranolol) is approved by the Food and Drug Administration (FDA) to treat it. Fortunately, recent studies have identified some additional medications as treatment of ET. Surgical procedures, such as deep brain stimulation of the ventral intermediate nucleus of the thalamus, offer treatment for refractory tremor. The epidemiology, pathogenesis, and medical and surgical treatment of ET will be discussed in this paper.

Keywords: Essential tremor, diagnosis, treatment, pathogenesis




 

Other articles by Professor Theresa Zesiewicz



Readers of this article also read:

Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: Comparison with high cardiovascular risk population
Gamma knife radiosurgery for uveal melanoma ineligible for brachytherapy by the Collaborative Ocular Melanoma Study criteria
Refinement of rigid-body protein–protein docking using backbone and side-chain minimization with a coarse-grained model
ABO and rhesus blood group distribution in Kurds
Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis
Amino acid management of Parkinson’s disease: a case study
Erratum
Update on treatment options for Lambert–Eaton myasthenic syndrome: focus on use of amifampridine
TiO2 micro-nano-hybrid surface to alleviate biological aging of UV-photofunctionalized titanium
Treatment-resistant depression in adolescents: is the addition of cognitive behavioral therapy of benefit?